ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
Allakos Inc

Allakos Inc (ALLK)

0.3127
0.0151
(5.07%)
마감 17 2월 6:00AM
0.3002
-0.0125
(-4.00%)
시간외 거래: 9:59AM

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
0.3002
매수가
0.3002
매도가
0.31
거래량
3,552,521
0.277 일간 변동폭 0.3197
0.23 52주 범위 1.69
market_cap
전일 종가
0.2976
개장가
0.2869
최근 거래 시간
500
@
0.3002
(formt)
마지막 거래 시간
재정 규모
US$ 1,043,374
VWAP
0.2937
평균 볼륨(3m)
2,295,924
발행 주식
89,343,634
배당수익률
-
주가수익률
-0.15
주당순이익(EPS)
-2.08
매출
-
순이익
-185.7M

Allakos Inc 정보

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Sig... Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Siglec-8, an inhibitory receptor found on eosinophils and mast cells. In preclinical and clinical studies, AK002 has been shown to deplete eosinophils and inhibit mast cells. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
Allakos Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker ALLK. The last closing price for Allakos was US$0.30. Over the last year, Allakos shares have traded in a share price range of US$ 0.23 to US$ 1.69.

Allakos currently has 89,343,634 shares in issue. The market capitalisation of Allakos is US$26.59 million. Allakos has a price to earnings ratio (PE ratio) of -0.15.

ALLK 최신 뉴스

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.0259.084302325580.27520.31270.255417655440.27910029CS
4-0.6978-69.91983967940.9981.260.2358938510.28948565CS
12-0.5661-65.34687752510.86631.380.2322959240.39846196CS
26-0.3822-56.00820633060.68241.5550.2313522090.56532906CS
52-0.9898-76.72868217051.291.690.239704910.74452294CS
156-6.1098-95.31669266776.418.730.2311692253.37959975CS
260-69.7498-99.57144896570.05157.980.23102019413.43618736CS

ALLK - Frequently Asked Questions (FAQ)

What is the current Allakos share price?
The current share price of Allakos is US$ 0.3002
How many Allakos shares are in issue?
Allakos has 89,343,634 shares in issue
What is the market cap of Allakos?
The market capitalisation of Allakos is USD 26.59M
What is the 1 year trading range for Allakos share price?
Allakos has traded in the range of US$ 0.23 to US$ 1.69 during the past year
What is the PE ratio of Allakos?
The price to earnings ratio of Allakos is -0.15
What is the reporting currency for Allakos?
Allakos reports financial results in USD
What is the latest annual profit for Allakos?
The latest annual profit of Allakos is USD -185.7M
What is the registered address of Allakos?
The registered address for Allakos is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Allakos website address?
The website address for Allakos is www.allakos.com
Which industry sector does Allakos operate in?
Allakos operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
JTAIJet AI Inc
US$ 6.02
(133.33%)
104.48M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
254.39M
WRDWeRide Inc
US$ 31.4877
(83.39%)
21.07M
INLFINLIF Limited
US$ 16.27
(80.58%)
7.68M
MBRXMoleculin Biotech Inc
US$ 2.1201
(66.94%)
136.66M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3.08
(-56.31%)
430.77k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3.36
(-52.68%)
5.21k
CSAICloudastructure Inc
US$ 19.0001
(-49.58%)
1.03M
NEXNNexxen International Ltd
US$ 10.30
(-49.16%)
164.82k
BSLKBolt Projects Holdings Inc
US$ 0.6626
(-46.13%)
13.4M
CNSPCNS Pharmaceuticals Inc
US$ 0.1415
(31.26%)
480.49M
MGOLMGO Global Inc
US$ 0.7176
(-15.08%)
411.17M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
248.48M
INTCIntel Corporation
US$ 23.60
(-2.20%)
225.04M
NVDANVIDIA Corporation
US$ 138.85
(2.63%)
189.56M

ALLK Discussion

게시물 보기
glenn1919 glenn1919 4 월 전
ALLK.................................https://stockcharts.com/h-sc/ui?s=ALLK&p=W&b=5&g=0&id=p86431144783
👍️0
wesley_ wesley_ 4 월 전
nice set up
👍️0
Banjo50 Banjo50 5 월 전
IS THIS STOCK A SCAM OR WHAT??? I WANT THE TRUTH!!!
👍️0
Monksdream Monksdream 11 월 전
ALLK 10Q due 3/19
👍️0
Monksdream Monksdream 11 월 전
ALLK under $2
👍️0
Monksdream Monksdream 11 월 전
ALLK 10Q due March 12
👍️0
Monksdream Monksdream 11 월 전
ALLK 10Q due March 5
👍️0
glenn1919 glenn1919 12 월 전
ALLK..........................................................................https://stockcharts.com/h-sc/ui?s=ALLK&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 12 월 전
ALLK under $2
👍️0
RobH1312 RobH1312 3 년 전
THIS POS IS A SCAM GONNA GO DOWN DOWN DOWN!!!

















imo
👍️0
REAGAN REAGAN 3 년 전
We will go short on this one.
👍️0
FROZENFLAME FROZENFLAME 3 년 전
Agree, the next couple weeks should be very interesting .
👍️0
REAGAN REAGAN 3 년 전
The whole Nasdaq is crashing. A stock whose IP doesn’t work should be pulverized next week.
👍️0
REAGAN REAGAN 3 년 전
Made it go down 95%. The technology doesn’t work….
👍️0
FROZENFLAME FROZENFLAME 3 년 전
It was a good flip, still looks attractive at this level, but I will wait .
👍️0
REAGAN REAGAN 3 년 전
This aged well
👍️0
FROZENFLAME FROZENFLAME 3 년 전
Allakos Inc. (the “Company” or “Allakos”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, today reported data from ENIGMA 2, a 24-week Phase 3 randomized, double-blind, placebo-controlled study of lirentelimab in patients with biopsy confirmed eosinophilic gastritis (EG) and/or eosinophilic duodenitis (EoD) and KRYPTOS, a 24-week Phase 2/3 randomized, double-blind, placebo-controlled study of lirentelimab in patients with biopsy-confirmed eosinophilic esophagitis (EoE). Both ENIGMA 2 and KRYPTOS studies met their histologic co-primary endpoints, but did not achieve statistical significance on the patient reported symptomatic co-primary endpoints.
“We are deeply disappointed that the studies did not achieve their symptomatic endpoints,” said Robert Alexander, PhD, Chief Executive Officer of Allakos. “The company is grateful to the patients with eosinophilic gastrointestinal diseases (EGIDs) and to the investigators who participated in the ENIGMA and KRYPTOS trials.”
👍️0
REAGAN REAGAN 3 년 전
Zero squeeeze. What’s up with this company. How’d it lose 97% of value in one year?
👍️0
REAGAN REAGAN 3 년 전
So what’s the deal with this stock? Why has the stock price fallen 97%? Where do you see the company has $500m cash on hand?
👍️0
BullofLA BullofLA 3 년 전
Yup, total scam, run away.
👍️0
Inves2day Inves2day 3 년 전
Allakos holders - please read and share the link below.


Stock wash sale 30 days period ended on 21 January 2022. December sellers will be looking to buy back now. Two after hours buys yesterday make more sense now.

ALLK is a forgotten share, but not for those who have to buy it back. The seller is gone for two days, but the sentiment is negative around all Nasdaq shares hence negative ends on Thu and Fr. This will change too.
I saw on Thursday 20 January that there was an appetite to climb up, really. Virtually no seller around. During the day all was going well, MMs were ticking it nicely higher until that moment of crash caused by Netflix followed by the entire Nasdaq falling down. Friday Nasdaq still down so ALLK too. But every crash ends and reversal starts for new buyers.

Look, as ALLK holders, we all can and have to create a need for shorters and those who sold in December for tax reasons to start the buy back. We need an bigger action to close day at 5-10% up to get noticed in media.
I. e. ADGI reversed exactly after 30 days wash sale. Allakos can do the same if we really want it.

Sell only if you really have to or Hold it for a few more days to see if recovery kicks in with Nasdaq stabilising.

Allakos Inc at $7 mcap is slightly lower than cash and equivalents.
We know they did not deliver but ffs share is down from $84 to $7 and they still be looking to use thst drug in another areas.

Please share the below post on Twitter for awareness.

https://twitter.com/inves2day/status/1485023226753437698?t=aK2TQngCviUwopFKMOEmjQ&s=19


Thank you for reading and sharing.

*23 Jan - my account on StockTwits has been suspended after posting the above link*
👍️0
Banjo50 Banjo50 3 년 전
IS THIS STOCK A SCAM OR WHAT??? I WANT THE TRUTH!!!
👍️0
donwillems donwillems 3 년 전
well this has 3 stages for me, everything +9.50, allright
everything above 10+, superb
everything above 12.50, winner winner chicken dinner.

A company with 500 million up their sleeves, I think they might figure something out.

And whats more, why did I buy into this company?
I have EOE myself, it's being triggered by cow milk with me and my throat and stumach gets hurt really bad by the eosiphiniles If I don't watch out with avoiding everything with milk.

I'm totally wondered here how that however the drug significantly reducing the eosiphiniles in situ doesn't get a response on the symptons, this starts me wondering if the direct symptons only thrive by the (food)allergy people have with it.

For now, I avoid milk and use omeprazole to completly suppres the effects, corticosteriod can be used locally but they are bad for blood vessels long term.

To get to the point, I think this drug isn't wrote off at all, the eosiphiniles do damage the throat a lot long term in this disease, if left untreathed, the throat will start forming circular scars, making it smaller and making it long term impossible to get food into the stumach.

The research completly ignores this problem, while it's the second main cause for treating this disease, unimaginable if you ask me.
👍️0
FROZENFLAME FROZENFLAME 3 년 전
Sure she’s trying to breakout !
👍️0
FROZENFLAME FROZENFLAME 3 년 전
Squeeze !
👍️0
FROZENFLAME FROZENFLAME 3 년 전
Dip and rip, short trying so hard !!
👍️0
da_stock_analyst da_stock_analyst 3 년 전
Two Stocks to Watch: #NXTD ?? #ALLK ?? Should you buy now for the possible run-up? Technical analysis!
👍️0
Huti Huti 3 년 전
20??? Maybe??? What do you guys think?
👍️0
forgiveness7x7 forgiveness7x7 3 년 전
DD here Can someone Box/Sticky it
https://twitter.com/tryingBot05/status/1473861479309152257
https://twitter.com/RealTimeTradez/status/1473987872197914633/photo/1
https://twitter.com/SilentTrader93/status/1474112595133177859
https://twitter.com/RealTimeTradez/status/1473809286354583557
https://twitter.com/RealTimeTradez/status/1474081174448398343
👍️0
forgiveness7x7 forgiveness7x7 3 년 전
ALLK New Patient Dec.21 2021
https://twitter.com/RealTimeTradez/status/1473987872197914633/photo/1
👍️0
forgiveness7x7 forgiveness7x7 3 년 전
https://twitter.com/SilentTrader93/status/1474112595133177859/photo/1
👍️0
forgiveness7x7 forgiveness7x7 3 년 전
https://twitter.com/RealTimeTradez/status/1473809286354583557/photo/1
👍️0
forgiveness7x7 forgiveness7x7 3 년 전
https://twitter.com/RealTimeTradez/status/1474081174448398343/photo/1
👍️0
forgiveness7x7 forgiveness7x7 3 년 전
https://twitter.com/tryingBot05/status/1473861479309152257/photo/1
👍️0
FROZENFLAME FROZENFLAME 3 년 전
Next week should be sooo good IMO .
👍️0
Laszlo1 Laszlo1 3 년 전
Took a starter
👍️0
forgiveness7x7 forgiveness7x7 3 년 전
that's what i'm here scouting out. looks like analysts have different opinions on price. from 10.00 to 60.00
i think it is a short attack and whatever else
👍️0
Laszlo1 Laszlo1 3 년 전
What happened here what causes the huge drop?
👍️0
FROZENFLAME FROZENFLAME 3 년 전
Huge volume over 63M $$$
👍️0
FROZENFLAME FROZENFLAME 3 년 전
Agree, a little bit more Consolidations, before the next leg up, then BOOOOM .
👍️0
alchemytrader alchemytrader 3 년 전
10.79
👍️0
Justfactsmam Justfactsmam 3 년 전
looks like the Short Squeeze commencing!
👍️0
FROZENFLAME FROZENFLAME 3 년 전
Very small SS short squeeze will take it to the moon .
👍️0
FROZENFLAME FROZENFLAME 3 년 전
I’m good with $50 lol .
👍️0
sirglenn sirglenn 3 년 전
Maybe they'll buy their own stock. LOL.
👍️0
Justfactsmam Justfactsmam 3 년 전
And GOLDMAN lowered the price target to $60.00...(6X) from here. Some see things others don't.
👍️0
crudeoil24 crudeoil24 3 년 전
9.91 > Morgan Stanley Maintains Equal-Weight on Allakos, Lowers Price Target to $10
All these analysts are comedians!
👍️0
FROZENFLAME FROZENFLAME 3 년 전
Expecting $15-$20 next week .
👍️0
FROZENFLAME FROZENFLAME 3 년 전
Over $10 premarket .
👍️0
maximumgriff maximumgriff 3 년 전
It’s never too late :)
👍️0

최근 히스토리

Delayed Upgrade Clock